| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Vvi19g0047 | ATGAGTACAAACCTATATGAAAGTTTCTATATATATATATATATATATATATATATATACTCTCAAAAATCAATCTTATTATTATTACACTTTACAGTGGAAGCTCTGGAAGAGATCGCGAAAACTCTGGGGAAGACGGACTGGAACTTCAGTGCGGATCCATGCGGCGGCGAGTGGGGTTGGGCGACGAAGAATCCGGTGAAGGGGTCGGAAAATGCTGTCACTTGTAGCTGCACCAACAACACTGTTTGCCATGTTGTTGGCATAGTCCTCAAGACTCAGAATCTCCCGGGATCTCTCCCACCAGAGCTGGTGAAGCTTCCTTACCTCCAAGAAATTGACTTCACCCGCAACTACCTCAACGGTTCAATCCCTCCAGAATGGGGTACAATGCAACTAGTAAACATTTCTCTGATGGGAAACCGGTTGACGGGTTCGATTCCCAAAGAGCTTGGAAACATCTCTACTCTTGCAAACCTAACCGTAGAGTCCAATCAGCTTTCAGGGGTTCTTCCTCAGGAGCTTGGGAATCTGCCCAGTATAGAGAGAATACTTCTTACCTCAAACAACTTCACTGGGGAGTTACCAGAAACATTTGCAGGGCTTACCACATTGAAGGACTTTCGGGTTGCAGATAATCAGTTCACAGGAAAGATACCCAATTTTATACAGAACTGGACAAAACTTGAAAAATTAGTGATTCATGGGAGTGGTTTCAGTGGGCCTATTCCTTCTGGCATTGCCCTTTTGACAAAAATAACTGACTTGAGAATCAGTGACCTGAATGGAACTGAAGCAACTTTTCCACCATTGAGTGATATGAGAAACTTGAAAACACTGATATTGAGGAGTTGCAGTATTGTTGGCCCGCTACCTGATTACCTTGGGGAAATGACAAAATTGAAAACCCTAGATCTGAGTTTTAACAAACTAACTGGAGAAATTCCAAGCAGCTTTGTCGGTCTATCAAAGGCAGATTACATATATTTTACCGGAAACATGCTAACTGGAGCCGTGCCTGATTGGATGCTGAAAAGAGGAGACAACTATGATCTTTCATACAATAACTTTACTAGTGAAAGCTCAAGAGGATGTCAAGAACGGAGTGTAAATTTGTTTGGAAGCTCATCAGGAGGAAATAACTCTGGAATTGTCTCGTGCTTGAGAAGCTTTAATTGCCCAAAAAAGTTTTACTCCATGCACATAAATTGTGGTGGAAAAGAAGTAATTGTTGATGGAAATACCACATATGAAGATGACAAAGATTCTGGTGGACCATCAAAGTTCTATCAGAGTAGAACAAACTGGGCATTCAGCAGCACAGGTCACTTCATGGACGATGACCATCCTACGGACTCCTTTATTGGGACAAACGTGTCTAGACTCGCCATGGAAAATTCTGGACTGTATACAACCGCACGCCTCTCCGCCCTGTCTCTCACTTATTATGGATTCTGTCTAGAAAATGGAAACTACACAGTAAAGCTTCACTTTGCAGAGATCACCTTTACTGATGACAAAACATATAGCAGCCTTGGAAGGCGTTTGTTTGATGTTTATGTTCAGGATGAGCTAGTTCTCAAGGATTTCAATATTGAGGATGAAGCAGGGGGTGTTAGCAAGGAAATCTTAAAATTTTTTACTGCAATTGTGACTAATAATACCTTGGAAATTCGCTTCTATTGGGCTGGGAAAGGGACTACAGGTATCCCAGTTAGAGGAGTTTACGGTCCTCTTATATCAGCTATTTCTGTGGACCCTGATTTTATACCTCCTACTGAAAATAGAAGCAGTAGCATATCTGTTGGCATTGTGGTTGGCGTTGTGGTTGGCATTGTGGCTGGAGTCATTCTTCTTGTCTTCCTGGTTATAGGTATCCTTTGGTGGAGAGTCTGCCTAAGGCGCAAAGATACGTTGGAACAAGAGTTAAAGGGTCTTGATCTGCAGACTGGTTTGTTTACCTTAAGGCAAATTAAGGCTGCCACAAACAACTTTGATGCTGCCAACAAAATTGGAGAAGGTGGATTTGGTTCTGTTTACAAGGGTGTCTTATCCGATGGCACCATAATTGCAGTGAAGCAGCTTTCTTCCAAATCAAAACAAGGAAACCGTGAGTTTGTGACTGAGATAGGCATGATTTCTGCTCTTCAACATCCTCATCTTGTGAAGCTCTATGGCTGTTGTATAGAAGGAAATCAGTTGTTGCTGATATACGAGTACATGGAAAATAACAGCCTCGCTCGTGCTTTGTTTGGCCCTGAAGAATGTCAATTACAATTGGATTGGCCAACTAGACACAGGATCTGTGTTGGCATAGCAAGAGGGTTGGCTTATCTTCATGAAGAATCAAGGCTGAAGATCGTCCACCGAGACATCAAGGCCACAAATGTGCTTCTTGATAAGGATCTTAACCCCAAAATATCTGACTTTGGTTTGGCCAAACTTGATGAAGAGTATAACACCCACATTAGCACGCGGATTGCTGGTACATTTGGATATATGGCACCTGAATATGCAATGCGGGGCTATTTAACCGACAAAGCAGATGTTTACAGTTTTGGAGTTGTTGCCTTGGAAATTGTCAGTGGAAGAAGCAACACTACTTATAGGCCAAAAGAAGAATCCATCTATCTTCTTGATCGGGCACTCTCTTTAAAAGAGAAGGGGAGCTTAATGGATATAGTTGACCCCAGATTGGGCTCAGACTTCAACAAGGAAGAGGTCATGGCAATGCTCAACATAGCTCTCCTGTGCACGACCATCTCTTCAGCAGTCAGGCCAGCTATGTCATCAGTTGTGAGCATGCTTGAAGGCAGAACTGCTGTTCAGGACATCGTTTCTGATCCCAGTGCTCCTAGTGATGACTTAAAGCTCGAGGAGATGAAGGAGCATTATCGCCACATCCAAGAAAAGAGCATGGGCGTGAGCGAGAGCAAGGCTCAGAGCATGCCAGATGGGCCATGGACTGCTTCTTCATCCATCCCTGATCTCTACCCAGTCAACTTGGATTCTGAATATTGGGAGAAGAGAGATTAA | 3036 | 0.4302 | MSTNLYESFYIYIYIYIYIYSQKSILLLLHFTVEALEEIAKTLGKTDWNFSADPCGGEWGWATKNPVKGSENAVTCSCTNNTVCHVVGIVLKTQNLPGSLPPELVKLPYLQEIDFTRNYLNGSIPPEWGTMQLVNISLMGNRLTGSIPKELGNISTLANLTVESNQLSGVLPQELGNLPSIERILLTSNNFTGELPETFAGLTTLKDFRVADNQFTGKIPNFIQNWTKLEKLVIHGSGFSGPIPSGIALLTKITDLRISDLNGTEATFPPLSDMRNLKTLILRSCSIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSKADYIYFTGNMLTGAVPDWMLKRGDNYDLSYNNFTSESSRGCQERSVNLFGSSSGGNNSGIVSCLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDKDSGGPSKFYQSRTNWAFSSTGHFMDDDHPTDSFIGTNVSRLAMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHFAEITFTDDKTYSSLGRRLFDVYVQDELVLKDFNIEDEAGGVSKEILKFFTAIVTNNTLEIRFYWAGKGTTGIPVRGVYGPLISAISVDPDFIPPTENRSSSISVGIVVGVVVGIVAGVILLVFLVIGILWWRVCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYKGVLSDGTIIAVKQLSSKSKQGNREFVTEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEYNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGVVALEIVSGRSNTTYRPKEESIYLLDRALSLKEKGSLMDIVDPRLGSDFNKEEVMAMLNIALLCTTISSAVRPAMSSVVSMLEGRTAVQDIVSDPSAPSDDLKLEEMKEHYRHIQEKSMGVSESKAQSMPDGPWTASSSIPDLYPVNLDSEYWEKRD* | 1012 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Vvi19g0047 | 1011 | Gene3D | - | 397 | 587 | - | - | |
| Vvi19g0047 | 1011 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase | 741 | 948 | - | - | |
| Vvi19g0047 | 1011 | Gene3D | Transferase(Phosphotransferase) domain 1 | 741 | 950 | - | - | |
| Vvi19g0047 | 1011 | FunFam | Leucine-rich repeat transmembrane protein kinase | 198 | 400 | - | - | |
| Vvi19g0047 | 1011 | Pfam | Malectin domain | 399 | 583 | IPR021720 | - | |
| Vvi19g0047 | 1011 | SUPERFAMILY | Protein kinase-like (PK-like) | 649 | 947 | IPR011009 | - | |
| Vvi19g0047 | 1011 | ProSiteProfiles | Protein kinase domain profile. | 665 | 951 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vvi19g0047 | 1011 | Gene3D | Ribonuclease Inhibitor | 157 | 223 | IPR032675 | - | |
| Vvi19g0047 | 1011 | Gene3D | Ribonuclease Inhibitor | 30 | 156 | IPR032675 | - | |
| Vvi19g0047 | 1011 | Gene3D | Phosphorylase Kinase; domain 1 | 630 | 740 | - | - | |
| Vvi19g0047 | 1011 | Gene3D | Ribonuclease Inhibitor | 224 | 371 | IPR032675 | - | |
| Vvi19g0047 | 1011 | MobiDBLite | consensus disorder prediction | 974 | 998 | - | - | |
| Vvi19g0047 | 1011 | PANTHER | LEUCINE-RICH REPEAT-CONTAINING PROTEIN DDB_G0281931-RELATED | 29 | 972 | - | - | |
| Vvi19g0047 | 1011 | ProSitePatterns | Protein kinases ATP-binding region signature. | 671 | 693 | IPR017441 | GO:0005524 | |
| Vvi19g0047 | 1011 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase isoform A | 32 | 190 | - | - | |
| Vvi19g0047 | 1011 | FunFam | probable LRR receptor-like serine/threonine-protein kinase At1g53430 | 634 | 740 | - | - | |
| Vvi19g0047 | 1011 | SUPERFAMILY | L domain-like | 74 | 342 | - | - | |
| Vvi19g0047 | 1011 | CDD | STKc_IRAK | 671 | 938 | - | - | |
| Vvi19g0047 | 1011 | Pfam | Protein tyrosine and serine/threonine kinase | 668 | 877 | IPR001245 | GO:0004672|GO:0006468 | |
| Vvi19g0047 | 1011 | MobiDBLite | consensus disorder prediction | 968 | 998 | - | - | |
| Vvi19g0047 | 1011 | Pfam | Leucine rich repeat | 275 | 335 | IPR001611 | GO:0005515 | |
| Vvi19g0047 | 1011 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase | 397 | 588 | - | - | |
| Vvi19g0047 | 1011 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 787 | 799 | IPR008271 | GO:0004672|GO:0006468 | |
| Vvi19g0047 | 1011 | SMART | serkin_6 | 665 | 936 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Vvi19g0047 | Vvi-Chr19 | 535286 | 547165 | Dispersed/Tandem |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Vvi19g0047 | 34 | 985 | Receptor kinase-like Gene Family | AT1G53420 | 56.667 | 0.0 | 1083 |
| Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
|---|---|---|---|---|---|---|---|
| PK | RLK-Pelle_DLSV | Vvi19g0047 | PK_Tyr_Ser-Thr | 2e-46 | CL0016 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Vvi19g0047 | - | - | vvi:100253721 | 1914.81 |